Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review.

Area of Science:

• Gastroenterology and Surgical Science
• Regenerative Medicine
• Pharmacology

Background:

• Visceral surgery frequently involves resection and reconnection of hollow gastrointestinal organs.
• Anastomotic healing and integrity are critical for successful surgical outcomes.
• Complications such as fistulas and dysfunction of various systems can arise post-surgery.

Purpose of the Study:

• To review the therapeutic potential of BPC 157 in healing distinct gastrointestinal anastomoses.
• To explore BPC 157's efficacy in managing associated surgical complications.
• To assess BPC 157's role in healing various types of fistulas.

Main Methods:

• Review of studies investigating BPC 157 therapy.
• Analysis of anastomoses including esophagogastric, colocolonic, jejunoileal, and ileoileal.
• Examination of BPC 157's effect on conditions like esophagitis, colitis, and short bowel syndrome.
• Evaluation of BPC 157's impact on fistula healing (e.g., colocutaneous, rectovaginal).

Main Results:

• BPC 157 therapy demonstrated significant healing of diverse gastrointestinal anastomoses.
• The therapy effectively counteracted associated disturbances like sphincter dysfunction and NO-system dysfunction.
• BPC 157 promoted the healing of various internal and external fistulas, including those involving the skin.
• Simultaneous healing of intestinal anastomoses and fistulas was observed.

Conclusions:

• BPC 157 therapy is a promising approach for enhancing the healing of gastrointestinal anastomoses.
• The peptide's ability to heal fistulas suggests a broad regenerative capacity.
• BPC 157 may represent a novel therapeutic strategy to improve outcomes in visceral surgery.